Enjoy complimentary customisation on priority with our Enterprise License!
The diuretic drugs market share is expected to increase to USD 95.64 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.44%.
This diuretic drugs market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers diuretic drugs market segmentation by product type (loop diuretics, thiazide diuretics, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The diuretic drugs market report also offers information on several market vendors, including AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd. among others.
Download the Free Report Sample to Unlock the Diuretic Drugs Market Size for the Forecast Period and Other Important Statistics
The increasing incidence of hypertension among people is notably driving the diuretic drugs market growth, although factors such as price pressure and availability of counterfeiter drugs may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the diuretic drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Diuretic Drugs Market Driver
Key Diuretic Drugs Market Trend
Key Diuretic Drugs Market Challenge
This diuretic drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global diuretic drugs market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the diuretic drugs market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the diuretic drugs market encompasses successful business strategies deployed by the key vendors. The diuretic drugs market is concentrated and the vendors are deploying growth strategies such as investments in R&D to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The diuretic drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the diuretic drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for diuretic drugs in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The high incidence of hypertension, increased healthcare expenditure, high awareness about hypertension, and associated risk factors among patients will facilitate the diuretic drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 pandemic adversely affected all the countries in North America in 2020, especially the US. However, it only had a slight negative impact on the diuretic drug market in North America. However, by H1 2021, lockdown-related restrictions were relaxed in several countries, which included the resumption of regular clinical visits due to the COVID vaccination drives from Q4 2020. Thus, the resumption of pharmaceutical manufacturing and logistic units will cater to the demand for diuretic drugs in North America through both online and offline channels, and the market in focus will register an accelerating growth momentum during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The diuretic drugs market share growth in the loop diuretic drugs segment will be significant during the forecast period. Loop diuretic drugs include furosemide, bumetanide, and torasemide. These diuretic drugs have greater bioavailability, a longer half-life, and higher potency than other diuretic drugs available in the market. Therefore, it is anticipated that the loop diuretic drugs segment will witness high growth in the forecast years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the diuretic drugs market size and actionable market insights on the post-COVID-19 impact on each segment.
Diuretic Drugs Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.44% |
Market growth 2022-2026 |
$ 95.64 million |
Market structure |
Concentrated |
YoY growth (%) |
4.29 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, Denmark, China, and India |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.